Arrowstreet Capital, Limited Partnership »

BioCryst Pharmaceuticals shares owned by Arrowstreet Capital, Limited Partnership

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Arrowstreet Capital, Limited Partnership from 13F filings

Historical chart of Arrowstreet Capital, Limited Partnership investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Arrowstreet Capital, Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Arrowstreet Capital, Limited Partnership

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.3M 431k 7.60

More positions owned by Arrowstreet Capital, Limited Partnership

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
At&t (T)
Eli Lilly & Co. (LLY)
Wells Fargo & Company (WFC)
JPMorgan Chase & Co. (JPM)
General Motors Company (GM)
Bank of America Corporation (BAC)
Comcast Corp Cl A (CMCSA)
Altria (MO)
MercadoLibre (MELI)
Hca Holdings (HCA)
Netflix (NFLX)

View all positions for Arrowstreet Capital, Limited Partnership

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Kynam Capital Management
State Street Corporation
Deerfield Management Company
Alkeon Capital Management
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group

View all funds holding BioCryst Pharmaceuticals